J&J | JNJ - Current Liabilities

Stock Price
227.50
Daily Change
-3.15 -1.37%
Monthly
-5.18%
Yearly
47.17%
Q2 Forecast
222.63

J&J reported $57.72B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Abbott USD 16.5B 1.91B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
CONMED USD 315.04M 342K Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intuitive Surgical USD 2.51B 3.2M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Medtronic USD 9.5B 440M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025
Zoetis USD 2.24B 428M Dec/2025